Table 5 Treatment and outcomes of thromboembolism in children with primary nephrotic syndrome
Sites | Number of patients followed-up/total patients | Follow-up duration, median (min, max days) | Serious complication (n) | Outcomes of thrombosis | |||
|---|---|---|---|---|---|---|---|
D (n) | I (n) | R (n) | S (n) | ||||
RV | 8/9 | 52 (26, 173) | 0 | 7 | 1 | 0 | 0 |
PA | 4/7 | 100 (76, 128) | 1, hypoxemia and pulmonary hypertension | 2 | 2 | 0 | 0 |
DVL | 6/6 | 34 (6, 133) | 0 | 5 | 1 | 0 | 0 |
CVS | 6/6 | 106 (35, 1095) | 1, persistent intracranial hypertension | 2 | 4 | 1 | 0 |
IVC | 3/3 | 102, 50, 76 | 0 | 3 | 0 | 0 | 0 |
PV | 1/2 | 33 | 0 | 1 | 0 | 0 | 0 |
SMV | 2/2 | 33, 54 | 1, intestinal necrosis | 2 | 0 | 0 | 0 |
IJV | 1/1 | 30 | 0 | 0 | 1 | 0 | 0 |
CA | 2/2 | 25, 85 | 0 | 1 | 1 | 0 | 2a |
PA | 1/1 | 78 | 1, lameness | 1 | 0 | 0 | Lameness |